Sol Gel Technologies Ltd (SLGL NASDAQ) stock market data APIs
$70.0978
0.06(0.1%)
as of May 7, 2026
Try our APIs with
free plan!
Sol Gel Technologies Ltd Financial Data Overview
Price chart is built with
Anychart
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Prev. Close
70.0978
Open
70.1579
High
70.6309
Low
67.7992
52 wk Range
6.8-97.97
Market Cap
232 M
Shares Outstanding
3 245 K
Revenue
19 388 K
EPS
0
Beta
1.171
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Sol Gel Technologies Ltd data using free add-ons & libraries
Get Sol Gel Technologies Ltd Fundamental Data
Sol Gel Technologies Ltd Fundamental data includes:
- Net Revenue: 19 388 K
- EBITDA: -7 483 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Sol Gel Technologies Ltd Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-05-08
- EPS/Forecast: -1.63
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sol Gel Technologies Ltd News
New
US Equity Indexes Fall Amid Uncertainty Over US-Iran Truce Talks
US equity indexes fell on Tuesday as oil prices continued to rise amid uncertainty surrounding truce PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Sol-Gel Technologies Prices Oversubscribed Offering, Stock Down
(RTTNews) - Sol-Gel Technologies Ltd. (SLGL) announced the pricing of an oversubscribed underwritten public offering, underscoring strong investor interest in its dermatology-focused pipeline. The co...
Sol-Gel Technologies prices over $33M offering for SGT-610 at $72 per share
[FDA approved concept. Rubber stamp with FDA and medicine.] Bet_Noire/iStock via Getty Images * Sol‑Gel Technologies (SLGL [https://seekingalpha.com/symbol/SLGL]) priced [https://seekingalpha.com...
Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering
NESS ZIONA, Israel, March 23, 2026 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (the “Company”) (NASDAQ: SLGL) today announced the pricing of an underwritten offering of 459,112 ordinary shares...
Get Sol Gel Technologies Ltd fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
